子宫内膜异位症患者ART周期中MRI发现子宫腺肌症降低活产率
这项观察性研究纳入202例子宫内膜异位症女性,在2015年6月至2018年7月期间接受IVF/ICSI治疗,评估MRI诊断的子宫腺肌症对活产率的影响。子宫腺肌症总体患病率为71.8%(145/202),累计活产率为57.4%(116/202)。多因素分析显示,子宫腺肌症(OR 0.48,95%CI 0.29-0.99,P=0.048)及T2高信号肌层斑点(OR 0.43,95%CI 0.22-0.86,P=0.018)与累计活产机会降低独立相关。
要点
- 子宫内膜异位症患者中,MRI诊断的子宫腺肌症与ART累计活产率降低独立相关(OR 0.48)。
- T2高信号肌层斑点的存在与活产机会降低独立相关(OR 0.43)。
- 作者建议对子宫内膜异位症女性进行适当影像学检查以筛查子宫腺肌症并个体化管理。
核心结论
- 对于接受ART的子宫内膜异位症女性,MRI发现子宫腺肌症(尤其是肌层内T2高信号斑点)对活产率有负面影响。
研究设计与样本
- 观察性研究,纳入2015年6月至2018年7月期间在一家三级医疗中心接受IVF/ICSI治疗的202例子宫内膜异位症女性,年龄18至42岁,均在接受ART前评估时进行了盆腔MRI检查。
- 患者随访至完成四个ART周期、分娩或完成四个周期前停止治疗,主要结局为最多四个IVF/ICSI周期后至少一名活产婴儿的分娩。
主要发现
- 患者平均年龄为32.5 ± 3.7岁,深部浸润型子宫内膜异位症占90.1%(182/202),子宫腺肌症(内层和/或外层肌层病变)占71.8%(145/202),累计活产率为57.4%(116/202)。
- 活产组女性显著更年轻(32.0 ± 3.3 vs 33.3 ± 4.1,P=0.026),卵巢储备参数(抗苗勒管激素水平、窦卵泡计数)显著更优。
- 子宫腺肌症的存在(不论表型)在活产组中显著更少(76/116(65.5%)vs 69/86(80.2%),P=0.022),T2高信号肌层斑点在活产组中也显著更少(27/116(23.3%)vs 37/86(43.0%),P=0.003)。
- 多因素分析显示,子宫腺肌症的存在(OR 0.48,95%CI 0.29-0.99,P=0.048)和T2高信号肌层斑点的存在(OR 0.43,95%CI 0.22-0.86,P=0.018)与累计活产机会降低独立相关。
临床怎么用
- 作者认为,对于子宫内膜异位症女性,医生应进行适当的影像学检查以筛查子宫腺肌症、识别预后因素,并在ART背景下个体化患者管理策略。
局限性
- 纳入来自专治子宫内膜异位症女性的转诊中心的患者可能构成选择偏倚,因为这些女性可能具有特别严重的子宫腺肌症和/或子宫内膜异位症。
- 子宫腺肌症尚无共识分类且多种病变可共存,因此实践中难以比较有无子宫腺肌症女性的生育结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the impact of adenomyosis on the live birth rate (LBR) in women affected by endometriosis women undergoing ART? SUMMARY ANSWER: For women undergoing ART, the presence of adenomyosis at MRI, especially T2 high-signal intensity spots within the myometrium, has a negative impact on the LBR. WHAT IS KNOWN ALREADY: Adenomyosis is a common gynecological disease. The development of imaging techniques for the diagnosis has led to several adenomyosis phenotypes being described, and fertility issues appear to vary according to the characteristics of the lesions. What makes assessment of the impact of adenomyosis on fertility issues even more difficult is its frequent association with endometriosis, which is another known risk factor of infertility. Although data suggest that adenomyosis may worsen the ART prognosis, there is no clear consensus regarding the impact of adenomyosis on ART outcomes in women affected by endometriosis. STUDY DESIGN, SIZE, DURATION: This was an observational study that included phenotyped patients with endometriosis, aged between 18 and 42 years, who underwent IVF/ICSI treatment in a tertiary care center between June 2015 and July 2018. Only women who had undergone a pelvic MRI during the pre-therapeutic ART workup were retained for this study. The MRI data were interpreted by radiologists who had expertise in gynecological MRI. PARTICIPANTS/MATERIALS, SETTING, METHODS: A continuous series of 202 women affected by endometriosis was included. The women were monitored until four ART cycles had been completed, until delivery, or until discontinuation of treatment before the completion of four cycles. The primary outcome was the delivery of at least one live infant after up to four IVF/ICSI cycles. The patient and the MRI characteristics were compared between the women who achieved a live birth versus those who did not. MAIN RESULTS AND THE ROLE OF CHANCE: The patients' mean age was 32.5 ± 3.7 years. Deep infiltrating endometriosis was present in 90.1% (182/202) of the included population. Adenomyosis (lesions of the internal and/or the external myometrium) was found in 71.8% (145/202) of the included women. The cumulative LBR was 57.4% (116/202). The women who gave birth were significantly younger (32.0 ± 3.3 versus 33.3 ± 4.1, P = 0.026) and had significantly better ovarian reserve parameters (anti-Müllerian hormone levels, antral follicle count) than those who did not. The presence of adenomyosis, irrespective of the phenotype (76/116 (65.5%) versus 69/86 (80.2%), respectively, P = 0.022) and the presence of T2 high-signal intensity myometrial spots (27/116 (23.3%) and 37/86 (43.0%), respectively, P = 0.003) was significantly less frequent in the group of women who gave birth versus those who did not. After multivariate analysis, the presence of adenomyosis (odds ratio (OR): 0.48, 95% CI (0.29-0.99), P = 0.048) and the presence of T2 high-signal intensity myometrial spots (OR: 0.43, 95% CI (0.22-0.86), P = 0.018) were independently found to be associated with a decrease in the cumulative chance of live birth. LIMITATIONS, REASONS FOR CAUTION: The inclusion of patients from a referral center specialized in the management of women affected by endometriosis could constitute a selection bias, as these women may have had particularly severe forms of adenomyosis and/or endometriosis. A sensitive issue is that there is no consensual classification of adenomyosis and several lesions of adenomyosis can co-exist. Therefore, a comparison of fertility outcomes between women with and without adenomyosis is difficult to perform in practice. WIDER IMPLICATIONS OF THE FINDINGS: In women exhibiting endometriosis, the practitioner should perform an appropriate imaging workup to search for adenomyosis, identify prognostic factors, and personalize the patient management strategy in the setting of ART. STUDY FUNDING/COMPETING INTEREST(S): No funding was obtained and there were no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Bourdon M, Santulli P, Bordonne C, et al. Presence of adenomyosis at MRI reduces live birth rates in ART cycles for endometriosis. Hum Reprod. 2022. PMID: 35460419. doi:10.1093/humrep/deac083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。